Aminoglycoside induced ototoxicity
Related Experiment Video
Updated: Jul 4, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
1Duke University, Department of Biology, Developmental, Cell and Molecular Biology (DCMB) Group, French Family Science Center, Durham, NC 27708-0338, USA. owg@duke.edu
Abstract:
Aminoglycosides are bactericidal aminoglycosidic aminocyclitols. They are cost effective and therefore widely used, however ototoxicity is a prominent dose-limiting side effect. Aminoglycoside induced ototoxicity leads to permanent bilaterally severe, high-frequency sensorineural hearing loss and temporary vestibular hypofunction. The permanent hearing loss is accompanied by degeneration of hair cells and neurons in the cochlea. An iron-aminoglycoside complex is believed to potentiate ROS-induced cellular degeneration in the cochlea. The development of aminoglycoside otoprotective strategies is a primary goal in ototoxicity research. Animal experiments have provided encouraging evidence for the protection of cochlear hair cells and neurons from aminoglycoside toxicity. However, the extent to which such protection, generalize to human ototoxicity remains unresolved.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
09:06Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Estimation of k and VD of Aminoglycosides
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Antifungal Agents
Drug Toxicity: Dose-Dependent Reactions